Doximity (DOCS) Earnings Analysis

Doximity (DOCS) has no confirmed upcoming earnings date. Last quarter (2026-02-05) it beat with EPS 0.46 USD vs 0.44 USD est (+4.5%). It has beaten estimates in 5/5 recent quarters (100%). Trailing P/E 19.70.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DOCS next report earnings?

No confirmed upcoming earnings date is currently scheduled for DOCS. This page updates as the calendar is published.

DOCS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-050.46 USD0.44 USD+4.5%Beat
2025-11-060.45 USD0.3787 USD+18.8%Beat
2025-08-070.36 USD0.3016 USD+19.4%Beat
2025-05-150.38 USD0.2716 USD+39.9%Beat
2025-02-060.45 USD0.31 USD+45.2%Beat

Beat rate: 5/5 (100%) over reported quarters with consensus data.

DOCS valuation and analyst view

Trailing P/E19.70
Trailing EPS1.061 USD
Price / book3.98
Dividend yield0.00%
Market cap3.81B
Analyst consensusHold (9 buy / 13 hold / 1 sell)
Avg price target24.08 USD

Related research pages

Frequently asked questions

When is Doximity (DOCS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for DOCS. This page updates as the calendar is published.

Did DOCS beat earnings last quarter?

In its 2026-02-05 report, DOCS posted EPS of 0.46 USD versus a 0.44 USD estimate — a beat of 4.5%.

What is DOCS's earnings track record?

Over the last 5 reported quarters with consensus data, DOCS beat estimates 5 times (100%).

What is DOCS's current P/E ratio and EPS?

DOCS trades at a trailing P/E of 19.70 on trailing EPS of 1.0605836020167485 USD.

What do analysts rate DOCS?

Analyst consensus is "Hold" across 23 ratings (1 strong buy, 8 buy, 13 hold, 1 sell, 0 strong sell). Average 12-month price target: 24.08 USD.